{
    "title": "GlaxoSmithKline's diabetes drug under fresh scrutiny",
    "url": "https://www.dailymail.co.uk/money/article-1293501/GlaxoSmithKlines-diabetes-drug-fresh-scrutiny.html",
    "date": "2010-07-09",
    "keywords": [
        "drug",
        "avandia",
        "safety",
        "heart",
        "research",
        "gsk",
        "july",
        "treatment",
        "fda",
        "week",
        "pill",
        "cleveland",
        "clinic",
        "risk",
        "graham",
        "rosiglitazone",
        "hoos",
        "scrutiny",
        "bawden",
        "gmt",
        "view",
        "future",
        "food",
        "administration",
        "tuesday",
        "meeting",
        "agency",
        "sale",
        "europe",
        "business",
        "bitter",
        "glaxosmithkline",
        "share",
        "price",
        "thisismoneycouk",
        "link",
        "panel",
        "action",
        "david",
        "office",
        "surveillance",
        "epidemiology",
        "head",
        "cardiology",
        "ohio",
        "failure",
        "director",
        "tony",
        "yesterday",
        "option",
        "type",
        "banning",
        "restriction",
        "blow",
        "year",
        "firm"
    ],
    "category": [
        "money"
    ]
}